Blokhin's Russian Cancer Research Center clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-11-17 | NCT07942168 Doxorubicin Plus Dacarbazine Versus Doxorubicin Alone as First-Line Therapy for… | Phase 2 | Recruiting |
Active trials by phase
| Phase 2 | 8 | |
| Phase 3 | 3 |
Not charted: 7 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Colorectal Cancer (7) · Esophageal Cancer (3) · Gastric Cancer (3) · Breast Cancer (2) · Bladder Cancer (1) · Glioblastoma (1) · Glioma (1) · HER2-Positive Cancer (1) · Sarcoma (1)
Get alerts when Blokhin's Russian Cancer Research Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.